Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

Market Cap	56.93B
Revenue (ttm)	4.27B
Net Income (ttm)	308.94M
Shares Out	1.11B
EPS (ttm)	0.27
PE Ratio	187.67
Forward PE	108.42
Dividend	0.42 (0.81%)
Ex-Dividend Date	n/a

Volume	5,022,600
Average Volume	3,331,545
Open	51.30
Previous Close	51.32
Day's Range	50.12 - 53.34
52-Week Range	29.13 - 62.65
Beta	-0.05
RSI	37.63
Earnings Date	Apr 13, 2026

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 5,337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002653

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.